ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of RDC-1036 (ALKS 37) in
adults with opioid-induced constipation (OIC) following repeat dose administration